[08 March 2013]
Products Affected - Description
All presentations are available.
Reason for the Shortage
- APP had protamine on shortage due to increased demand.
- There are no other manufacturers of protamine sulfate.
Available Products
Protamine Sulfate 10 mg/mL, American Pharmaceutical Partners (APP)
5 mL vials (NDC 63323-0229-05)
5 mL Novaplus vials (NDC 63323-0229-15)
25 mL vials (NDC 63323-0229-30)
25 mL Novaplus vials (NDC 63323-0229-35)
Estimated Resupply Dates
All presentations are available.
Related Shortages
Updated
March 8, 2013; February 1, 2013; November 6, 2012; September 4, 2012; June 29, 2012; May 23, 2012; May 1, 2012; March 27, 2012; February 15, 2012; January 13, 2012; November 28, 2011; October 26, 2011; September 29, 2011; August 24, 2011; July 28, 2011; July 15, 2011; June 23, 2011; June 1, 2011; May 19, 2011; May 6, 2011; May 5, 2011; April 22, 2011 University of Utah, Drug Information Service. Copyright 2013, Drug Information Service, University of Utah, Salt Lake City, UT.
Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins